Arkivoc 2018, vii, 0-0
Florea, C. A. et al.
Spectral data of selected compounds
1
The H and 13C NMR chemical shifts of the following compounds are referenced to internal (CH3)4Si (δH = 0)
and CDCl3 (δC = 77.16 ppm).42 Aromatic ortho, meta, and para hydrogens or carbons are labeled o, m, and p,
respectively; ipso carbons are abbreviated as i. All NMR data were in accordance with those cited in literature,
but with complete assignments. In addition, the corresponding MS data are presented, except for 4c
(unstable), 16 and 17 (experimental limitations).
3
1-Benzylazetidine (1c).35,36 1H-NMR (300 MHz, CDCl3) δ (ppm) 2.07 (2H, quintet, J 7.1 Hz, N-CH2-CH2), 3.20
(4H, t, 3J 7.1 Hz, CH2-N-CH2), 3.55 (2H, s, Ph-CH2), 7.20-7.32 (5H, m, arom.). 13C-NMR (75 MHz, CDCl3) δ (ppm)
17.6 (N-CH2-CH2), 55.1 (CH2-N-CH2), 63.9 (Ph-CH2), 126.8 (p), 128.2 (o), 128.4 (m), 138.4 (i). EI-MS [70 eV, m/z
(relative abundance, %)]: 147 (M+; 22), 146 (47), 92 (9.5), 91 (100), 70 (5.5), 65 (11).
1-Benzylaziridine (1d).27 1H-NMR (300 MHz, CDCl3) δ (ppm) 1.23-1.29 + 1.78-1.83 (2+2H, m+m, CH2-CH2), 3.37
(2H, s, Ph-CH2), 7.20-7.40 (5H, m, arom.). 13C-NMR (75 MHz, CDCl3) δ (ppm) 27.6 (CH2-CH2), 65.3 (Ph-CH2),
127.1 (p), 128.0 (o), 128.4 (m), 139.3 (i). EI-MS [70 eV, m/z (relative abundance, %)]: 133 (M+; 13), 132 (45),
105 (6.0), 104 (8), 92 (8), 91 (100), 89 (7), 77 (10), 65 (22), 63 (7), 51 (10), 42 (57).
1-Benzylazetidine-1-oxide (4c).36 1H-NMR (400 MHz, CDCl3) δ (ppm) 1.90-1.94 + 2.33-2.40 (1+1H, m+m, N+-
CH2-CH2), 4.25-4.29 (4H, m, CH2-N+-CH2), 4.41 (2H, s, Ph-CH2), 7.33-7.44 (3H, m, m+p), 7.54 (2H, d, J 6.4 Hz, o).
13C-NMR (100 MHz, CDCl3) δ (ppm) 12.1 (N+-CH2-CH2), 68.9 (CH2-N+-CH2), 70.2 (Ph-CH2), 128.4 (p), 129.3 (m),
130.1 (i), 131.9 (o).
1-Benzyl-2-azetidinone (5c).37 1H-NMR (300 MHz, CDCl3) δ (ppm) 2.94 (2H, t, J 4.0 Hz, N-CH2-CH2), 3.12 (2H, t, J
4.0 Hz, N-CH2-CH2), 4.36 (2H, s, Ph-CH2), 7.25-7.35 (5H, m, arom.). 13C-NMR (75 MHz, CDCl3) δ (ppm) 36.6 (N-
CH2-CH2), 38.3 (N-CH2-CH2), 46.0 (Ph-CH2), 127.5 (p), 128.0 (o), 128.5 (m), 135.5 (i), 167.5 (CO). EI-MS [70 eV,
m/z (relative abundance, %)]: 161 (M+; 41.5), 133 (28.5), 132 (11), 105 (55), 104 (15), 92 (8.5), 91 (100), 77
(24).
1
1-Benzoylazetidine (6c).38 (the underlined signals show the C-H correspondence). H-NMR (300 MHz, CDCl3) δ
(ppm) 2.32 (2H, quintet, J 7.4 Hz, N-CH2-CH2), 4.22 + 4.28 (2+2H, t+t, J 7.4 Hz, CH2-N-CH2 ), 7.32-7.48 (3H, m,
m+p), 7.62 (2H, dd, 3J 7.8 Hz, 4J 1.5, o). 13C-NMR (75 MHz, CDCl3) δ (ppm) 15.9 (N-CH2-CH2), 48.7 + 53.2 (CH2-N-
CH2 ), 127.6 (o), 128.1 (m), 130.7 (p), 133.1 (i), 170.1 (CO). EI-MS [70 eV, m/z (relative abundance, %)]: 161 (M+,
25), 160 (7), 106 (8.5), 105 (100), 77 (43.5).
1-Benzoylaziridine (6d).39 1H-NMR (300 MHz, CDCl3) δ (ppm) 2.39 (4H, s, CH2-CH2), 7.55-7.65 (3H, m, m+p),
8.07 (2H, d, J 7.6 Hz, 2H, o). 13C-NMR (75 MHz, CDCl3) δ (ppm) 26.1 (CH2-CH2), 128.0 (o), 129.3 (m), 132.9 (p),
134.2 (i), 179.3 (CO). EI-MS [70 eV, m/z (relative abundance, %)]: 147 (M+, 7), 105 (100), 77 (72), 51 (19).
1-Benzylazetidine-2-carbonitrile (12c).24 1H-NMR (300 MHz, CDCl3) δ (ppm) 2.35-2.45 (2H, m, N-CH2-CH2),
3.12+3.35 (1+1H, q+q, J 7.2 Hz, N-CH2-CH2), 3.64+3.72 [1+1H, d+d (ABq), JAB 13.2 Hz, Ph-CH2], 3.90 (1H, t, J 7.2
Hz, CH-CN), 7.15-7.18 (5H, m, arom.). 13C-NMR (75 MHz, CDCl3) δ (ppm) 22.9 (N-CH2-CH2), 51.7 (CH-CN), 52.4
(N-CH2-CH2), 60.8 (Ph-CH2), 118.8 (CN), 127.5 (o), 128.6 (p), 128.8 (m), 136.1 (i). EI-MS [70 eV, m/z (relative
abundance, %)]: 172 (M+, 22), 171 (20), 120 (9), 95 (8), 92 (15), 91 (100), 81 (6), 65 (13).
2-Phenyloxazoline (14).43 1H-NMR (300 MHz, CDCl3) δ (ppm) 4.05 (2H, t, J 9.2 Hz, N-CH2), 4.41 (2H, t, J 9.2 Hz,
O-CH2), 7.35-7.50 (3H, m, m+p), 7.94 (2H, d, J 7.8 Hz, o) 13C-NMR (75 MHz, CDCl3) δ (ppm) 54.9 (N-CH2), 67.5
(O-CH2), 127.7 (i), 128.1+128.2 (o+m), 131.2 (p), 164.4 (C=N). EI-MS [70 eV, m/z (relative abundance, %)]: 148
(10), 147 (M+, 85), 118 (15), 117 (100), 105 (12), 91 (13), 77 (25), 51 (13).
1,4-Dibenzylpiperazine (15).10 1H-NMR (300 MHz, CDCl3) δ (ppm) 2.48 (8H, s, CH2-CH2), 3.51 (4H, s, 4H, Ph-
CH2), 7.21-7.30 (10H, m, arom.). 13C-NMR (75 MHz CDCl3) δ (ppm) 53.1 (CH2-CH2), 63.1 (Ph-CH2), 127.0 (p),
128.2 (o), 129.2 (m), 138.2 (i). EI-MS [70 eV, m/z (relative abundance, %)]: 266 (M+, 25), 175 (42), 146 (11), 132
(12), 120 (28), 119 (7.5), 92 (8), 91 (100), 65 (9).
Page 11
©ARKAT USA, Inc